What is the share price of Gujarat Inject Kerala Ltd (GUJINJEC) today?
The share price of GUJINJEC as on 24th April 2025 is ₹20.20. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Gujarat Inject Kerala Ltd (GUJINJEC) share?
The past returns of Gujarat Inject Kerala Ltd (GUJINJEC) share are- Past 1 week: -16.58%
- Past 1 month: -27.23%
- Past 3 months: -24.37%
- Past 6 months: 10.38%
- Past 1 year: 35.73%
- Past 3 years: 1203.23%
- Past 5 years: 723.87%
What are the peers or stocks similar to Gujarat Inject Kerala Ltd (GUJINJEC)?
The peers or stocks similar to Gujarat Inject Kerala Ltd (GUJINJEC) include:What is the market cap of Gujarat Inject Kerala Ltd (GUJINJEC) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Gujarat Inject Kerala Ltd (GUJINJEC) is ₹29.33 Cr as of 24th April 2025.What is the 52 week high and low of Gujarat Inject Kerala Ltd (GUJINJEC) share?
The 52-week high of Gujarat Inject Kerala Ltd (GUJINJEC) is ₹29 and the 52-week low is ₹13.11.What is the PE and PB ratio of Gujarat Inject Kerala Ltd (GUJINJEC) stock?
The P/E (price-to-earnings) ratio of Gujarat Inject Kerala Ltd (GUJINJEC) is 325.86. The P/B (price-to-book) ratio is 3.43.Which sector does Gujarat Inject Kerala Ltd (GUJINJEC) belong to?
Gujarat Inject Kerala Ltd (GUJINJEC) belongs to the Materials sector & Diversified Chemicals sub-sector.How to buy Gujarat Inject Kerala Ltd (GUJINJEC) shares?
You can directly buy Gujarat Inject Kerala Ltd (GUJINJEC) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Gujarat Inject Kerala Ltd
GUJINJEC Share Price
GUJINJEC Share Price Chart
How to use scorecard? Learn more
GUJINJEC Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
29.62 | 3.43 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
29.95 | 3.41 | 1.39% |
GUJINJEC Analyst Ratings & Forecast
Detailed Forecast Price Upside
Earnings Growth
Rev. Growth
GUJINJEC Company Profile
Gujarat Inject (Kerala) Limited is involved in the manufacture of other chemical products. The Company operates in India.
GUJINJEC Similar Stocks (Peers)
Compare with peersGUJINJEC Forecasts
Price
Revenue
Earnings
GUJINJEC Share Price Forecast
GUJINJEC Company Revenue Forecast
GUJINJEC Stock EPS (Earnings Per Share) Forecast
GUJINJEC
Income
Balance Sheet
Cash Flow
GUJINJEC Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 2.32 | 1.57 | 0.05 | 0.02 | 0.01 | 0.02 | 0.07 | 0.60 | 5.85 | 20.40 | ||||||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.15 | 5.40 | 19.19 | ||||||||||
Power & Fuel Cost | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||
Employee Cost | 0.01 | 0.01 | 0.02 | 0.01 | 0.00 | 0.01 | 0.03 | 0.03 | ||||||||||||
Selling & Administrative Expenses | 0.00 | 0.03 | 0.05 | 0.01 | 0.04 | 0.04 | 0.01 | 0.12 | ||||||||||||
Operating & Other expenses | 0.01 | 1.52 | 0.00 | 0.00 | 0.08 | 0.00 | 0.36 | 0.19 | ||||||||||||
EBITDA | 2.30 | 0.01 | -0.02 | 0.00 | 0.00 | -0.11 | 0.00 | 0.05 | 0.11 | 1.21 | ||||||||||
Depreciation/Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
PBIT | 2.30 | 0.01 | -0.02 | 0.00 | 0.00 | -0.11 | 0.00 | 0.05 | 0.11 | 1.21 | ||||||||||
Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
PBT | 2.30 | 0.01 | -0.02 | 0.00 | 0.00 | -0.11 | 0.00 | 0.05 | 0.11 | 1.21 | ||||||||||
Taxes & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.22 | ||||||||||
Net Income | 2.30 | 0.01 | -0.02 | 0.00 | 0.00 | -0.11 | 0.00 | 0.04 | 0.09 | 0.99 | ||||||||||
EPS | 4.69 | 0.02 | -0.04 | 0.00 | 0.00 | -0.22 | 0.00 | 0.08 | 0.11 | 0.88 | ||||||||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | — | — | 0.00 | — | 0.00 | 0.00 | 0.00 |
GUJINJEC Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFGUJINJEC Past Performance & Peer Comparison
MaterialsDiversified Chemicals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Gujarat Inject Kerala Ltd | 325.86 | 3.43 | — |
Pidilite Industries Ltd | 90.20 | 18.10 | 0.52% |
SRF Ltd | 66.59 | 7.75 | 0.24% |
PI Industries Ltd | 32.99 | 6.35 | 0.41% |
GUJINJEC Stock Price Comparison
Compare GUJINJEC with any stock or ETFGUJINJEC Shareholdings
GUJINJEC Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
GUJINJEC Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
GUJINJEC Shareholding Pattern
GUJINJEC Shareholding History
smallcases containing GUJINJEC stock
Looks like this stock is not in any smallcase yet.
GUJINJEC Events
GUJINJEC Dividend Trend
GUJINJEC has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
GUJINJEC Dividends
GUJINJEC Stock News & Opinions
Gujarat Inject (Kerala) announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 3 April 2025.Powered by Capital Market - Live
Gujarat Inject (Kerala) will hold a meeting of the Board of Directors of the Company on 18 February 2025.Powered by Capital Market - Live
Gujarat Inject (Kerala) will hold a meeting of the Board of Directors of the Company on 5 February 2025.Powered by Capital Market - Live
Net profit of Gujarat Inject (Kerala) reported to Rs 0.21 crore in the quarter ended December 2024. There were no net profit/loss reported during the previous quarter ended December 2023. Sales rose 1331.82% to Rs 3.15 crore in the quarter ended December 2024 as against Rs 0.22 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales3.150.22 1332 OPM %8.89-18.18 - PBDT0.280 0 PBT0.280 0 NP0.210 0 Powered by Capital Market - Live
Gujarat Inject (Kerala) will hold a meeting of the Board of Directors of the Company on 23 January 2025.Powered by Capital Market - Live
Net profit of Gujarat Inject (Kerala) rose 6000.00% to Rs 0.61 crore in the quarter ended September 2024 as against Rs 0.01 crore during the previous quarter ended September 2023. Sales reported to Rs 8.61 crore in the quarter ended September 2024. There were no Sales reported during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales8.610 0 OPM %6.270 - PBDT0.710.01 7000 PBT0.710.01 7000 NP0.610.01 6000 Powered by Capital Market - Live
Gujarat Inject (Kerala) will hold a meeting of the Board of Directors of the Company on 22 October 2024Powered by Capital Market - Live
Gujarat Inject (Kerala) announced that the Annual General Meeting (AGM) of the company will be held on 28 September 2024.Powered by Capital Market - Live
Net profit of Gujarat Inject (Kerala) rose 300.00% to Rs 0.12 crore in the quarter ended June 2024 as against Rs 0.03 crore during the previous quarter ended June 2023. Sales rose 1933.33% to Rs 3.05 crore in the quarter ended June 2024 as against Rs 0.15 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales3.050.15 1933 OPM %5.2526.67 - PBDT0.160.04 300 PBT0.160.04 300 NP0.120.03 300 Powered by Capital Market - Live
Gujarat Inject (Kerala) will hold a meeting of the Board of Directors of the Company on 10 August 2024.Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 211.33%, vs industry avg of 9.83%
Over the last 5 years, market share increased from 0% to 0.01%